Evidence map›Paper›PMID 31861726›Full record

ArticleBiomolecules2019

Protective Effects of Melatonin Against Aristolochic Acid-Induced Nephropathy in Mice.

Jung-Yeon Kim, Jaechan Leem, Eon Ju Jeon

Abstract read
In one paragraph

Article in Biomolecules, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. The Ginsenoside RgLife (Basel, Switzerland) · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jung-Yeon KimDepartment of Immunology, School of Medicine, Catholic University of Daegu, Daegu 42472, Korea.
Jaechan LeemDepartment of Immunology, School of Medicine, Catholic University of Daegu, Daegu 42472, Korea.ORCID 0000-0003-2329-4374
Eon Ju JeonDepartment of Internal Medicine, School of Medicine, Catholic University of Daegu, Daegu 42472, Korea.ORCID 0000-0002-8858-5343

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melatonin, a pineal hormone, is well known to regulate the sleep-wake cycle. Besides, the hormone has been shown to display pleiotropic effects arising from its powerful anti-oxidant and anti-inflammatory activities. Recent studies have reported that melatonin exerts protective effects in animal models of kidney disease. However, the potential effects of melatonin on aristolochic acid (AA)-induced nephropathy (AAN) have not yet been investigated. Here, we found that the administration of melatonin ameliorated AA-induced renal dysfunction, as evidenced by decreased plasma levels of blood urea nitrogen and creatinine and histopathological abnormalities such as tubular dilatation and cast formation. The upregulation of tubular injury markers after AA injection was reversed by melatonin. Melatonin also suppressed AA-induced oxidative stress, as evidenced by the downregulation of 4-hydroxynonenal and reduced level of malondialdehyde, and modulated expression of pro-oxidant and antioxidant enzymes. In addition, p53-dependent apoptosis of tubular epithelial cells, infiltration of macrophages and CD4

Indexed as

AnimalsApoptosisAristolochic AcidsCytokinesHumansKidneyKidney DiseasesMaleMelatoninMiceMice, Inbred C57BLTumor Suppressor Protein p53aristolochic acid IAristolochic AcidsCytokinesMelatoninTrp53 protein, mouseTumor Suppressor Protein p53apoptosisaristolochic acidfibrosisinflammationmelatoninnephropathyoxidative stress

Identifiers

PMID31861726
PMCPMC7023369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.